UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 96

of 'Treatment of relapsed or refractory chronic lymphocytic leukemia'

96
TI
From mitochondrial biology to magic bullet: navitoclax disarms BCL-2 in chronic lymphocytic leukemia.
AU
Walensky LD
SO
J Clin Oncol. 2012;30(5):554. Epub 2011 Dec 19.
 
AD
Dana-Farber Cancer Institute, Boston, MA 02215, USA. loren_walensky@dfci.harvard.edu
PMID